Miyakawa I - Search Results

1

Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.

Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Int J Mol Med. 2002 Aug;10(2):211-6. Int J Mol Med. 2002. PMID: 12119561

2

Ca(2+)/calmodulin-dependent protein kinase IV expression in epithelial ovarian cancer.

Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Cancer Lett. 2002 Sep 26;183(2):185-93. doi: 10.1016/s0304-3835(02)00107-6. Cancer Lett. 2002. PMID: 12065094

3

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.

Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Cancer Lett. 2002 Oct 8;184(1):105-16. doi: 10.1016/s0304-3835(02)00190-8. Cancer Lett. 2002. Retraction in: Cancer Lett. 2013 Aug 28;337(1):147. doi: 10.1016/j.canlet.2013.02.027 PMID: 12104054 Retracted.

4

CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma.

Shang S, Takai N, Nishida M, Miyazaki T, Nasu K, Miyakawa I. Shang S, et al. Among authors: miyakawa i. Int J Mol Med. 2003 Feb;11(2):181-6. Int J Mol Med. 2003. PMID: 12525874

5

Clinical relevance of Elf-1 overexpression in endometrial carcinoma.

Takai N, Miyazaki T, Nishida M, Shang S, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Gynecol Oncol. 2003 Jun;89(3):408-13. doi: 10.1016/s0090-8258(03)00131-8. Gynecol Oncol. 2003. PMID: 12798703

6

The significance of Elf-1 expression in epithelial ovarian carcinoma.

Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Int J Mol Med. 2003 Sep;12(3):349-54. Int J Mol Med. 2003. PMID: 12883651

7

The relationship between oncogene expression and clinical outcome in endometrial carcinoma.

Takai N, Ueda T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Curr Cancer Drug Targets. 2004 Sep;4(6):511-20. doi: 10.2174/1568009043332871. Curr Cancer Drug Targets. 2004. PMID: 15379636 Review.

8

Expression of c-Ets1 is associated with malignant potential in endometrial carcinoma.

Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Cancer. 2000 Nov 15;89(10):2059-67. doi: 10.1002/1097-0142(20001115)89:10<2059::aid-cncr5>3.0.co;2-3. Cancer. 2000. PMID: 11066046

9

Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage.

Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Cancer Lett. 2001 Mar 10;164(1):41-9. doi: 10.1016/s0304-3835(00)00703-5. Cancer Lett. 2001. PMID: 11166914

10

Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma.

Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyakawa i. Cancer Lett. 2001 Apr 26;165(2):185-93. doi: 10.1016/s0304-3835(01)00433-5. Cancer Lett. 2001. PMID: 11275368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters